Univest
Univest
  • Markets
  • 3 Global Generics Leader, Specialty Branded Generics Seller and Pain and Anti-Malarial Brand Owner Stocks With a Strong Future Roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories

    • October 26, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Global Generics Leader, Specialty Branded Generics Seller and Pain and Anti-Malarial Brand Owner Stocks With a Strong Future Roadmap: Dr. Reddy's Laboratories, Ajanta Pharma and Ipca Laboratories

    Global Generic and Specialty Pharma Stocks with a strong future roadmap: Dr. Reddy’s Laboratories, Ajanta Pharma and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Specialty Pharma Maker, Global Generics Leader and Branded Medicines Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Dr. Reddy’s Laboratories and Alkem Laboratories

    • October 26, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Specialty Pharma Maker, Global Generics Leader and Branded Medicines Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Dr. Reddy's Laboratories and Alkem Laboratories

    Branded Pharma and Specialty Generics Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Dr. Reddy’s Laboratories and Alkem Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Global Generics and Specialty Franchise, Branded and Generic Leader and Active Ingredient Manufacturer Stocks With a Strong Future Roadmap: Lupin, Dr. Reddy’s Laboratories and Granules India

    • October 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Global Generics and Specialty Franchise, Branded and Generic Leader and Active Ingredient Manufacturer Stocks With a Strong Future Roadmap: Lupin, Dr. Reddy's Laboratories and Granules India

    Complex Generics and Active Ingredient Stocks with a strong future roadmap: Lupin, Dr. Reddy’s Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more
  • 3 Ingredients and Custom Manufacturing, Oral Solid Generics and Large Branded Generics Stocks With a Strong Future Roadmap: Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories

    • October 22, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Ingredients and Custom Manufacturing, Oral Solid Generics and Large Branded Generics Stocks With a Strong Future Roadmap: Neuland Laboratories, Strides Pharma Science and Dr. Reddy's Laboratories

    Pharma Ingredient and Generic Formulation Stocks with a strong future roadmap: Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Pharma Stocks With a Strong Future Roadmap: Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories

    • October 6, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Pharma Stocks With a Strong Future Roadmap: Sun Pharmaceutical Industries, Cipla and Dr. Reddy's Laboratories

    Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • Buy, Sell Or Hold: Wipro, Tech Mahindra, Dr Reddy’s Laboratories, Cipla, Britannia Industries — Analyst Forecast

    • September 24, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Buy, Sell Or Hold: Wipro, Tech Mahindra, Dr Reddy's Laboratories, Cipla, Britannia Industries — Analyst Forecast

    A look at 5 ESG stocks in India, Wipro, Tech Mahindra, Dr Reddy’s Laboratories, Cipla and Britannia Industries, with a buy, hold or sell view on each.

    read more
  • 1
  • 2